New pill combo shows promise for rare blood cancer patients who Can't get transplant
NCT ID NCT05782127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a combination of two oral medications, Onureg and Venclyxto, in people with a high-risk form of myelodysplastic syndromes (a blood cancer) who cannot have a stem cell transplant. The goal is to find the safest and most effective dose of Onureg when used with Venclyxto, and to see how well the combination works. About 36 adults will take part in this early-phase trial across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNTREATED MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Annecy Genevois
Épagny, 74370, France
-
CH Le Mans
Le Mans, 72037, France
-
CH Lyon sud
Lyon, 69495, France
-
CH Valence
Valence, 26000, France
-
CHI Mont-de-Marsan
Mont-de-Marsan, 40000, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU Nîmes - Institut de Cancérologie du Gard
Nîmes, 30029 cedex 9, France
-
CHU Saint Eloi
Montpellier, 34295, France
-
CHU d'Amiens Picardie - Site sud
Amiens, 80054, France
-
CHU d'Angers
Angers, 49033, France
-
CHU de Grenoble
Grenoble, 38043, France
-
CHU de Haut-Lévèque
Pessac, 33604, France
-
CHU de Limoges - Hôpital Dupuytren
Limoges, 87042, France
-
CHU de Poitiers
Poitiers, 86021, France
-
CHU de Tours - Hôpital Bretonneau
Tours, 37000, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Hôpital Archet 1
Nice, 06200, France
-
Hôpital Avicenne
Bobigny, 93009, France
-
Hôpital Brabois
Vandœuvre-lès-Nancy, 54500, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Saint Louis
Paris, 75010, France
-
Hôpital Saint Vincent de Paul
Lille, 59020, France
-
Hôpital privé Sévigné
Cesson-Sévigné, 35510, France
-
IUCT Oncopole
Toulouse, 31059, France
-
Institut Paoli Calmettes
Marseille, 13009, France